Latest Updates
-
Yash Birla Shows How Statement Dressing Can Redefine Individual Style In Indian Fashion -
World Saree Day 2025: From Fusion To Heritage, The Saree Trends That Ruled The Year -
SIR Draft Electoral Rolls Out In West Bengal, Gujarat, Tamil Nadu: How Voters Can Check SIR Form Submission Status Online? -
Gold Rate In India Crash By Rs 12,000 From Record: Will 24K, 22K, 18K Gold Prices Rise Or Fall In Christmas Week? Gold & Silver Prediction Here -
20th or 21st December? When Is the Winter Solstice In 2025 And How Is It Different From Meteorological Winter -
‘Clean Air Is a Right, Not a Luxury’: ZONAIR3D Unveils India Expansion Plans -
World Meditation Day 2025: Meditation Beyond The Mat, Simple Moments That Bring Inner Peace -
Sreenivasan Passes Away: Malayalam Cinema Mourns The Legendary Actor-Writer's Demise -
Malayalam Film Industry Loses A Defining Voice: Actor, Screenwriter And Director Sreenivasan Passes Away At 69 -
Happy Birthday Dheeraj Dhoopar: How A TV Set Friendship Turned Into Love With Wife Vinny Arora
COVID-19 Vaccination: Supply, Eligibility Will Decide Vax For Kids
The government will take a final decision on vaccinating children and adolescents against coronavirus on the basis of overall scientific rationale as well as the supply situation of vaccines available for those below 18 years, Covid task force chief V K Paul said on Sunday.
Paul also cautioned that even though infections were coming down and the second wave was subsiding, it would not be fair to say that the worst was over since many countries had seen more than two waves.

Currently, three vaccines - Covishield, Covaxin and Sputnik V - being administered in the country are only for those above 18. Zydus Cadila's needle-free vaccine ZyCoV-D is set to become the first that will be available in India for those between 12 and 18. It has received emergency use authorisation (EUA).
"We do know several countries have introduced vaccination for adolescents and children. We will make a final decision based on the overall scientific rationale and the supply situation of the child-licenced vaccines," Paul said.
An expert panel of India's central drug authority has recommended granting EUA to Bharat Biotech's Covaxin for children and adolescents in the 2-18 age group with certain conditions.
According to Paul, Covaxin is part of the adult vaccination programme and how to provide the vaccine, if at all for children, has to be also examined.
"A pragmatic decision can be taken (only) by balancing the supply and the potential eligibility," he said.
Paul said: "The preparation for incorporation of Zydus Cadila's vaccine into the vaccination programme is proceeding well, training is already being held."
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.



Click it and Unblock the Notifications











